ARYx Therapeutics, Inc.
ARYX · OTC
9/30/2010 | 6/30/2010 | 3/31/2010 | 12/31/2009 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,515 | -$3,636 | -$6,390 | -$5,787 |
| Dep. & Amort. | $206 | $231 | $251 | $261 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $138 | $162 | $477 | $207 |
| Change in WC | -$1,946 | -$325 | -$799 | -$858 |
| Other Non-Cash | $71 | $53 | $38 | $92 |
| Operating Cash Flow | -$4,046 | -$3,515 | -$6,423 | -$6,085 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$8 | $0 | $0 | -$44 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $281 | $204 | $370 | $7,309 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $273 | $204 | $370 | $7,265 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $5,301 | -$1,527 | -$1,484 | -$1,466 |
| Stock Issued | $22 | -$55 | $6,424 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $1 | $850 |
| Financing Cash Flow | $5,323 | -$1,582 | $4,941 | -$616 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1,550 | -$4,893 | -$1,112 | $564 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,404 | $6,297 | $7,409 | $6,845 |
| End Cash | $2,954 | $1,404 | $6,297 | $7,409 |
| Free Cash Flow | -$4,054 | -$3,515 | -$6,423 | -$6,129 |